J 104132

Drug Profile

J 104132

Alternative Names: L 753037

Latest Information Update: 22 Feb 2008

Price : $50

At a glance

  • Originator Banyu; Merck & Co
  • Class Pyridines
  • Mechanism of Action Endothelin A receptor antagonists; Endothelin B receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Heart failure; Hypertension

Most Recent Events

  • 05 Apr 2001 A preclinical study has been added to the Heart Failure pharmacodynamics section
  • 14 Dec 2000 Phase-I clinical trials for Congestive heart failure in Japan (PO)
  • 14 Dec 2000 Phase-II clinical trials for Congestive heart failure in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top